Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

October 4, 2021

Study Completion Date

August 4, 2023

Conditions
Lung Cancer
Trial Locations (27)

Unknown

Centro Oncologico Riojano, La Rioja

Instituto De Oncologia De Rosario, Santa Fe

Centro Medico San Roque, Córdoba

CRIO, Fortaleza

CLION, Salvador

NOB, Salvador

Hospital Sírio- Libanês, Brasília

ICTr, Curitiba

Hospital de Câncer de Londrina, Londrina

Hospital de Caridade de Carazinho, Carazinho

CPO, Porto Alegre

HCPA, Porto Alegre

Hospital Moinhos de Vento, Porto Alegre

Hospital Mãe de Deus, Porto Alegre

Clínica Reichow, Blumenau

CNT Itajaí, Itajaí

Barretos, Barretos

COI Américas, Rio de Janeiro

INCA, Rio de Janeiro

AC Camargo, São Paulo

IBCC, São Paulo

Fundación Arturo López Pérez, Providencia

Clínica del Country, Chapinero

Oncomedica, Montería

Hospital Pablo Tobon Uribe, Robledo

Centro Médico Nacional Siglo XXI, Mexico City

INCan, Mexico City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Latin American Cooperative Oncology Group

OTHER

NCT04227457 - Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America | Biotech Hunter | Biotech Hunter